Viewing nowCombinationCeltofor 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201401226 · Approved 2014.03.17 · Insurance code 693901240
Treatment of essential hypertension not controlled by monotherapy
This medication is used to control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus in the second and third trimesters of pregnancy, so if pregnancy is confirmed, you must stop taking it immediately. It should not be administered to patients with hypersensitivity to this medication, pregnant women, patients with severe kidney and liver impairment, or those with specific decreased kidney function. Patients with insufficient sodium or body fluids may be at risk of hypotension, so their condition should be stabilized before administration, and blood pressure should be carefully monitored during treatment. Potassium levels should be regularly checked in patients with high potassium levels or those taking medications that can increase potassium levels. This medication should be used cautiously in patients with renal artery stenosis, recent kidney transplant recipients, those with a history of angioedema, heart failure, and myocardial infarction, and it should be stopped immediately if any abnormal symptoms occur. As this medication lowers blood pressure, symptoms such as dizziness and drowsiness may occur, so caution is necessary when driving or operating machinery. This medication may interact with other specific medications, so if you are taking other drugs, you must inform your healthcare provider, and regular monitoring of kidney function, blood pressure, and electrolyte levels is required. Pregnant or breastfeeding women are advised not to use this medication, and women planning to become pregnant should consult with their healthcare provider. It is not recommended for use in pediatric patients under 18 years of age, as safety and efficacy have not been established. In case of overdose, severe hypotension or cardiac side effects may occur, so adherence to the prescribed dosage is essential, and any abnormal symptoms should prompt an immediate visit to the hospital.
Pharyngitis, influenza, hypersensitivity, visual disturbances, anxiety, headache, dizziness, drowsiness, position-related dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, frequent urination, polyuria, erectile dysfunction, edema, periorbital edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, increased liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gum hyperplasia, hepatitis, jaundice, alopecia, purpura, skin discoloration, phototoxic reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disturbances, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, leukopenia, thrombocytopenia, confusion, exfoliative dermatitis, Stevens-Johnson syndrome, phototoxic reactions, toxic epidermal necrolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain room temperature between 1 and 30 degrees Celsius.
Dark yellow round film-coated tablet
28 tablets (14 tablets/Alu-Alu x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.